Speakers

Speech Title : Surgical Fetal Stem Cell Transplant into Heart Failure Patients Long-term Results at 14 Years.

Dr. Federico Benetti is a distinguished Argentine cardiovascular surgeon and a pioneer in minimally invasive cardiac surgery. With decades of clinical, academic, and surgical experience, he has made significant contributions to the advancement of cardiac surgery through innovative techniques, international teaching, and research. Throughout his career, Dr. Benetti has authored numerous scientific publications, book chapters, and educational materials. He has delivered invited lectures worldwide and has trained cardiothoracic surgeons through live surgical demonstrations and international educational programs. He has also served on the editorial boards of scientific journals and is a member of several prestigious professional societies. Recognized with numerous awards for his contributions to cardiovascular medicine, Dr. Benetti continues to be an influential figure in the field, dedicated to advancing patient care, surgical education, and innovation in cardiac surgery.

Speech Title : KAPS-biomarker for early diagnosis of Prostate Cancer

Kailash Chadha is the Emeritus Associate Member and Associate Professor of Oncology in the Department of Molecular and Cellular Biology at Roswell Park Cancer Institute, and in Department of Medicine, State University of New York at Buffalo, NY, USA. He got his Ph.D. degree in Virology from the University of Guelph, Guelph, Ontario, Canada. After his graduation he spent two years as a fellow of National Research Council of Canada. Following that he joined Roswell Park Cancer Institute in Buffalo, New York as a Cancer Research Scientist in the Department of Medical Viral Oncology. His research interests are in the area of cell and molecular biology of Herpes viruses, interferons and prostate cancer. He has published well over 125 publications, written several book chapters and currently holds six U.S. patents. He has been invited to participate in numerous national and international scientific meetings and has often chaired sessions on several international meetings. He is currently on the editorial board of several journals including Prostate Cancer J, International J Nephrology & Urology, Cancer & Clinical Research, J. Nephrology Research and member of several professional organizations including New York Academy of Sciences; American Association for the Advancement of Science; Society for Experimental Biology & Medicine; American Association for Cancer Research; International Society for Interferon & Cytokine research and The Society of Basic Urologic Research etc. He has edited a book on interferons entitled “Interferons: Current Status, published by Research Signpost (ISBN 81-7736-256-9). His immediate research interest is in developing new ”biomarkers” for early detection and management of prostate cancer and in studying physiological role of prostate-specific antigen (PSA) in regulating prostate tumor growth and in-particular role of PSA in “angiogenesis”.

Speech Title : Enhancing Sustainable Healthcare Through The Ethical And Innovative Use Of Artificial Intelligence

Dr. Benjamin Anabaraonye is a researcher at the University of Nigeria, Nsukka, Nigeria. He is an environmental health advocate and well known conference speaker at reputable international conferences. Benjamin has received numerous trainings, professional certifications and awards in the field of public health and climate change from top academic institutions of the world. He is an award-winning poet, CEO, and founder of the Project Green educational blog: www.projectgreeninitiative.wordpress.com that features articles, events, and poems on climate change adaptation and mitigation for global sustainability.

Speech Title : Application of Nanotechnology to Enhance Molecular Stability in Erythrocyte Membranes During Preservation

Andrey N. Belousov, PhD, DM, Professor - a Ukrainian medical scientist and pioneer in nanotechnology, who developed the world’s first biocompatible nanomedical drugs “Micromage-B”, “MCS-B” and “ICNB”, officially registered and introduced into clinical practice since 1998. His work established a translational foundation for medical nanotechnology, linking fundamental biophysics with clinical applications in detoxification, hemocorrection, and neuroprotection. The published more 370 scientific works on results application of nanotechnology preparation in experimental and practical medicine. He has got 9 patents for the invention. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies, Professor of Department Anesthesiology, Intensive Care and Pediatric Anesthesiology of Kharkiv National Medical University, Ukraine.